The US Food and Drug Administration (FDA) is evaluating under priority review the regulatory submission of tolebrutinib to treat non-relapsing secondary progressive multiple sclerosis (nrSPMS) and to ...

Tolebrutinib is currently under clinical investigation, and its safety and efficacy have not been evaluated by any regulatory ...

Frailty is a complex syndrome that may be under-recognized yet can complicate the clinical trajectory of neurologic diseases ...

Post-flight rehabilitation for astronauts returning from space includes medical tests, physical therapy, and exercise ...

Nii, O. and Emeanulu, L. (2025) Effects of Housing Accessibility on the General Well-Being of International Students at the University of the West of Scotland (UWS). Open Access Library Journal, 12, 1 ...